Research analysts at Cantor Fitzgerald decreased their FY2025 earnings per share estimates for Beam Therapeutics in a note issued to investors on Wednesday, February 26th. Cantor Fitzgerald analyst R.

Xometry (NASDAQ:XMTR – Free Report) had its target price upped by Cantor Fitzgerald from $12.00 to $20.00 in a research note issued to investors on Wednesday morning,Benzinga reports. The brokerage ...

Blackwell is still in its early days, but at $11 billion, it made up nearly a third of Nvidia's data-center revenue, Cantor Fitzgerald analyst C.J. Muse noted. (Nvidia's data-center business ...

We recently compiled a list of the 10 Best 3D Printing Stocks To Buy Right Now. In this article, we are going to take a look ...

Fintel reports that on February 26, 2025, Cantor Fitzgerald downgraded their outlook for Jazz Pharmaceuticals (NasdaqGS:JAZZ) ...

Today, Benzinga's options scanner spotted 8 options trades for Riot Platforms. This isn't normal. The overall sentiment of ...

The Central Bank said the firm failed to put effective arrangements in place to detect and report suspicious transactions.

Cantor Fitzgerald analyst Andres Sheppard reiterated a Buy rating on Intuitive Machines (LUNR – Research Report) yesterday and set a price ...

Cantor Fitzgerald analyst Brett Knoblauch initiated coverage with a Buy rating on Core Scientific Inc (CORZ – Research Report) yesterday and ...

In a notable holding, the Delaware Supreme Court has confirmed that forfeiture-for-competition provisions generally are not subject to ...

Spotify CEO Daniel Ek escalates battle with Apple for allegedly flouting EU's Big Tech rules, challenges EU to enforce law ...

Nvidia (NVDA) is advancing 2.5% after the tech giant announced yesterday that it was widening its alliance with Cisco (CSCO).